Long term effectiveness and safety of teriflunomide in relapsing remitting multiple sclerosis, and improvement in quality of life: tericare study
Por:
Gonzalez, J, Meca, J, Caminero, A, Olaskoaga, J, Casanova, V, Varo, N, Llaneza, M, Berenguer, L, Casademont, R and Martinez, S
Publicada:
1 dic 2020
Resumen:
Filiaciones:
Gonzalez, J:
Hosp Clin Univ Santiago, Santiago De Compostela, Spain
Meca, J:
Hosp Virgen Arrixaca, Murcia, Spain
Caminero, A:
Complejo Asistencial Avila, Avila, Spain
Olaskoaga, J:
Hosp Univ Donostia, San Sebastian, Spain
Casanova, V:
Hosp Univ & Politecn La Fe, Valencia, Spain
Varo, N:
Hosp Univ Burgos, Burgos, Spain
Llaneza, M:
Hosp Ferrol, Ferrol, Spain
:
Hosp Marina Baixa Villajoyosa, Valencia, Spain
Casademont, R:
Sanofi, Barcelona, Spain
Martinez, S:
Sanofi, Barcelona, Spain
|